EA
MD icon

Evolution Advisers’s Pediatrix Medical MD Stock Holding History

Evolution Advisers’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Buy
+19
New +$432 ﹤0.01% 607

Other funds holding MD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Evolution Advisers's MD Position: Q2 2026 in Review

Evolution Advisers opened a new position in Pediatrix Medical (MD) in Q2 2026: 19 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #607 among its holdings.

303 funds tracked by Wall St. Rank hold MD as of Q2 2026.

  • Evolution Advisers held 19 shares of Pediatrix Medical worth $0 as of Q2 2026.
  • Pediatrix Medical was a new Evolution Advisers position in Q2 2026.
  • Pediatrix Medical made up ﹤0.01% of Evolution Advisers's portfolio in Q2 2026, its #607 holding.
  • 303 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Evolution Advisers's 13F filing for Q2 2026, filed 31 Jul 2026.